The Innovative Medicines Initiative (IMI) has launched its 100th project in the form of Hypo-RESOLVE, a 4 year, EUR 26.8 million project on diabetes. The milestone comes as IMI celebrates its 10th anniversary with a series of events and activities. The IMI project portfolio is diverse; many projects, like Hypo-RESOLVE, focus on specific health issues such as diabetes, neurological conditions (including dementia, depression, and pain), cancer, auto-immune diseases (such as rheumatoid arthritis), and infectious diseases (including antimicrobial resistance and Ebola).
Read more ...
The Big Ethical Questions for Artificial Intelligence in Healthcare
AI in healthcare is developing rapidly, with many applications currently in use or in development in the UK and worldwide. The Nuffield Council on Bioethics examines the current and potential applications of AI in healthcare, and the ethical issues arising from its use, in a new briefing note, Artificial Intelligence (AI) in healthcare and research, published today.
Read more ...
Data in the EU: Commission Steps Up Efforts to Increase Availability and Boost Healthcare Data Sharing
The European Commission is putting forward a set of measures to increase the availability of data in the EU, building on previous initiatives to boost the free flow of non-personal data in the Digital Single Market. Data-driven innovation is a key enabler of market growth, job creation, particularly for SMEs and startups, and the development of new technologies.
Read more ...
KONFIDO: An Innovative View of eHealth Security
The Horizon 2020 funded KONFIDO Action concluded its activities related to User Requirement Analysis. This initial phase of the Action entailed a gap analysis study about secure and interoperable solutions at the systemic level, the definition and analysis of user scenarios, the user requirements elicitation, and an intense interaction with the KONFIDO end-users (both patients/citizens and healthcare professionals) for the identification of barriers and facilitators concerning eHealth acceptance coupled with cybersecurity technologies.
Read more ...
Evaluating Diabetes Self-Help Tools
There is an increasing amount of self-help tools among people with diabetes. They use apps, social media and various cloud-based solutions to cope. Now, e-health researchers will make guidelines for evaluating the apps and online resources they use.
Read more ...
Assessing Health Technology in the EU: Commission Proposes to Reinforce Cooperation Amongst Member States
European Commission has put forward a proposal to boost cooperation amongst EU Member States for assessing health technology. Greater transparency will empower patients, by ensuring their access to information on the added clinical value of new technology that could potentially benefit them.
Read more ...
Augmented Reality System Lets Doctors See under Patients' Skin without the Scalpel
New technology is bringing the power of augmented reality into clinical practice. The system, called ProjectDR, allows medical images such as CT scans and MRI data to be displayed directly on a patient's body in a way that moves as the patient does.
Read more ...
The Innovative Medicines Initiative (IMI) has launched its 100th project in the form of Hypo-RESOLVE, a 4 year, EUR 26.8 million project on diabetes. The milestone comes as IMI celebrates its 10th anniversary with a series of events and activities. The IMI project portfolio is diverse; many projects, like Hypo-RESOLVE, focus on specific health issues such as diabetes, neurological conditions (including dementia, depression, and pain), cancer, auto-immune diseases (such as rheumatoid arthritis), and infectious diseases (including antimicrobial resistance and Ebola). 
The European Commission is putting forward a set of measures to increase the availability of data in the EU, building on previous initiatives to boost the free flow of non-personal data in the Digital Single Market. Data-driven innovation is a key enabler of market growth, job creation, particularly for SMEs and startups, and the development of new technologies. 